SCI is "Top Charity"
SCI recommended as a "Top Charity" for 7th consecutive year
GiveWell, an international charity evaluator, has recommended the SCI as a "Top Charity" once more for its impact and cost-effectiveness.
SCI recommended as a "Top Charity" for 7th consecutive year
GiveWell, an international charity evaluator, has recommended the SCI as a "Top Charity" once more for its impact and cost-effectiveness.
SCI awarded A+ rating by DFID for third year running
The SCI has received an excellent A+ rating from the UK government's
Department for International Development (DFID) for a third year running.
Funding received to complete paediatric schistosomiasis drug trial
European and Japanese funders have formed an exciting new partnership to complete the development of a paediatric schistosomiasis drug formulation.
The SCI team presents research at the ASTMH Annual Meeting 2017
SCI researchers attended the American Society of Tropical Medicine and Hygiene (ASTMH) Annual Meeting to present findings from a range of projects.
One donor's support to improving health in Africa
Individuals can make a huge difference to the health of the poorest people in Africa.
Ramping up efforts to control and eliminate schistosomiasis in Uganda
Delegates met between 30-31 August in Kampala, to discuss progress and next steps in the control and elimination of schistosomiasis.
SCI Open Evening 2017
SCI hosted a successful annual Open Evening on 28 June, attended by many of its supporters who came to enjoy a great evening with the SCI team.
Strengthening data capacity in Niger
SCI collaborated with Niger's Ministry of Health to provide training in data cleaning and analysis, to ensure treatment programmes perform optimally.
Mapping progress in schistosomiasis control in Uganda
Programmatic surveys have been completed to re-assess infection levels around Lake Victoria in Uganda, to determine an optimal treatment strategy.
SCI-supported treatment starts in Nigeria
The first round of SCI-supported treatment has started in Nigeria as part of a collaboration between SCI and Sightsavers.